Published in Can Med Assoc J on September 08, 1979
Amines: possible causative agents in the development of bronchial hyperreactivity in workers manufacturing polyurethanes from isocyanates. Br J Ind Med (1983) 1.33
Occupational asthma and extrinsic alveolitis due to isocyanates: current status and perspectives. Br J Ind Med (1993) 1.03
Quantitative plasma biomarker analysis in HDI exposure assessment. Ann Occup Hyg (2009) 0.79
Hemoglobin adducts in workers exposed to 1,6-hexamethylene diisocyanate. Biomarkers (2011) 0.77
In vitro effect of toluene diisocyanate on beta adrenergic and muscarinic receptor function in lung tissue of the rat. Br J Ind Med (1989) 0.77
Analysis of the interrelationship of the pulmonary irritation and elicitation thresholds in rats sensitized with 1,6-hexamethylene diisocyanate (HDI). Inhal Toxicol (2015) 0.75
Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy (1977) 14.37
Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection. Am Rev Respir Dis (1976) 6.26
Allergen-induced increase in non-allergic bronchial reactivity. Clin Allergy (1977) 4.42
Bronchial hyperreactivity. Br J Dis Chest (1975) 3.70
Asthma due to inhaled chemical agents, tolylene di-isocyanate. Clin Allergy (1972) 2.55
[Non-specific bronchial provocation tests in asthma (author's transl)]. Bull Eur Physiopathol Respir (1977) 1.85
Bronchial hyperirritability in healthy subjects after exposure to ozone. Am Rev Respir Dis (1978) 1.82
Toluene di-isocyanate (TDI) toxicity. N Engl J Med (1963) 1.74
Trimellitic anhydride-induced airway syndromes: clinical and immunologic studies. J Allergy Clin Immunol (1977) 1.71
Bronchial asthma and asthmatic bronchitis determined by simple chemicals. Dis Chest (1969) 1.63
Dimethyl ethanolamine-induced asthma. Am Rev Respir Dis (1977) 1.53
Relationship between bronchial reactivity, airway caliber, and severity of asthma. Am Rev Respir Dis (1977) 1.50
In vitro demonstration of specific IgE in phthalic anhydride hypersensitivity. Am Rev Respir Dis (1976) 1.45
Asthma due to aluminium soldering flux. Thorax (1967) 1.24
Clinical and immunologic appraisal of workers exposed to diisocyanates. Arch Environ Health (1968) 1.23
Asthma due to inhaled chemical fumes--amino-ethyl ethanolamine in aluminium soldering flux. Clin Allergy (1972) 1.13
Longitudinal study of workers employed in the manufacture of toluene-diisocyanate. Am Rev Respir Dis (1977) 1.13
Pulmonary toxicity of isocyanates. Ann Intern Med (1970) 1.13
RESPIRATORY ALLERGY DUE TO CHEMICAL COMPOUNDS ENCOUNTERED IN THE RUBBER, LACQUER, SHELLAC, AND BEAUTY CULTURE INDUSTRIES. J Allergy (1964) 1.08
Nonspecific bronchial hyperreactivity after exposure to Western Red Cedar. Am Rev Respir Dis (1979) 1.08
Toluene diisocyanate (TDI) pulmonary disease: immunologic and inhalation challenge studies. J Allergy Clin Immunol (1976) 1.07
Toluene diisocyanate pulmonary disease: immunopharmacologic and mecholyl challenge studies. J Allergy Clin Immunol (1977) 1.03
New tests to assess lung function. inhalation challenge tests in asthma. N Engl J Med (1975) 0.94
Immunological investigation of individuals with toluene diisocyanate asthma. Clin Exp Immunol (1969) 0.94
Allergy in fur workers with special reference to paraphenylenediamine. J Allergy (1959) 0.77
Prediction of creatinine clearance from serum creatinine. Nephron (1976) 64.02
Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy (1977) 14.37
Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med (2000) 9.44
Reproducibility and comparison of responses to inhaled histamine and methacholine. Thorax (1978) 4.77
Allergen-induced increase in non-allergic bronchial reactivity. Clin Allergy (1977) 4.42
Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl (1993) 3.82
Rapid onset of tolerance to the bronchoprotective effect of salmeterol. Chest (1995) 2.47
Protective effect of drugs on histamine-induced asthma. Thorax (1977) 2.02
Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine. J Allergy Clin Immunol (1987) 1.78
Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response. Am J Respir Crit Care Med (1997) 1.71
Standardization of inhalation provocation tests: influence of nebulizer output, particle size, and method of inhalation. J Allergy Clin Immunol (1981) 1.66
Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol. Chest (1996) 1.65
Bronchial responsiveness to inhaled histamine and exercise. J Allergy Clin Immunol (1979) 1.60
Mechanism of perennial allergic asthma. Lancet (1983) 1.58
Tolerance to the bronchoprotective effect of salmeterol 12 hours after starting twice daily treatment. Ann Allergy Asthma Immunol (1998) 1.58
Increased nonspecific bronchial reactivity in cigarette smokers with normal lung function. Am Rev Respir Dis (1980) 1.57
Determinants of allergen-induced asthma: dose of allergen, circulating IgE antibody concentration, and bronchial responsiveness to inhaled histamine. Am Rev Respir Dis (1979) 1.57
OX40L blockade and allergen-induced airway responses in subjects with mild asthma. Clin Exp Allergy (2014) 1.54
Dimethyl ethanolamine-induced asthma. Am Rev Respir Dis (1977) 1.53
Methacholine PC20 extrapolation. Chest (1998) 1.50
Right-sided aortic arch presenting as refractory intraoperative and postoperative wheezing. Chest (1991) 1.45
Single-dose desloratadine and montelukast and allergen-induced late airway responses. Eur Respir J (2009) 1.45
Unimodal distribution of bronchial responsiveness to inhaled histamine in a random human population. Chest (1983) 1.44
Indirect airway challenges. Eur Respir J (2003) 1.42
Reproducibility of allergen-induced early and late asthmatic responses. J Allergy Clin Immunol (1995) 1.25
Calcitonin from ultimobranchial glands of dogfish and chickens. Science (1967) 1.20
Prediction of airway responsiveness to allergen from skin sensitivity to allergen and airway responsiveness to histamine. Am Rev Respir Dis (1987) 1.16
Measurement of responsiveness to inhaled histamine using FEV1: comparison of PC20 and threshold. Thorax (1983) 1.13
Ultimobranchial origin of calcitonin. Hypocalcemic effect of extracts from chicken glands. Can J Physiol Pharmacol (1967) 1.12
Factors in allergen-induced asthma: relevance of the intensity of the airways allergic reaction and non-specific bronchial reactivity. Clin Allergy (1976) 1.11
Increased bronchial reactivity to inhaled histamine in nonsmoking grain workers with normal lung function. Chest (1980) 1.08
Asthma caused by occupational exposure to a furan-based binder system. J Allergy Clin Immunol (1980) 1.08
Nighttime ventilation improves respiratory failure in secondary kyphoscoliosis. Am Rev Respir Dis (1984) 1.08
Nonspecific bronchial hyperreactivity after exposure to Western Red Cedar. Am Rev Respir Dis (1979) 1.08
Miliary tuberculosis presenting with hyponatremia and thrombocytopenia. Can Med Assoc J (1976) 1.07
Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Eur Respir J (1993) 1.06
Determination of histamine PC20. Comparison of linear and logarithmic interpolation. Chest (1983) 1.05
Assessment of endotoxin levels in the home and current asthma and wheeze in school-age children. Indoor Air (2008) 1.05
Mycobacterium saskatchewanense sp. nov., a novel slowly growing scotochromogenic species from human clinical isolates related to Mycobacterium interjectum and Accuprobe-positive for Mycobacterium avium complex. Int J Syst Evol Microbiol (2004) 1.05
Bronchial response to inhaled histamine in asymptomatic young smokers. Eur J Respir Dis (1983) 1.02
Possible protective effect against chronic obstructive airways disease by the GC2 allele. Hum Hered (1990) 1.01
The beta-agonist controversy. Med Clin North Am (1996) 1.00
The allergen bronchoprovocation model: an important tool for the investigation of new asthma anti-inflammatory therapies. Allergy (2007) 0.98
Cigarette smoking, airway hyperresponsiveness, and asthma. Chest (1988) 0.97
Out-patient management of bronchial asthma. Can Fam Physician (1989) 0.96
Asthma management in the emergency department. Can Respir J (2000) 0.96
Slope of the dose-response curve: usefulness in assessing bronchial responses to inhaled histamine. Thorax (1983) 0.96
Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol. J Allergy Clin Immunol (2000) 0.96
Changes in bronchial responsiveness to histamine at intervals after allergen challenge. Thorax (1987) 0.94
Volume adjustment of maximal midexpiratory flow. Importance of changes in total lung capacity. Chest (1980) 0.94
Decrease in non-specific bronchial reactivity in an asthmatic following treatment of hyperthyroidism. Ann Allergy (1978) 0.93
Characteristics of airway tone during exercise in patients with asthma. J Appl Physiol Respir Environ Exerc Physiol (1983) 0.92
Effect of aerosolized anti-IgE (E25) on airway responses to inhaled allergen in asthmatic subjects. Am J Respir Crit Care Med (1999) 0.92
Beclomethasone dipropionate aerosol in allergic rhinitis. Can Med Assoc J (1976) 0.91
Evaluation of single-dose inhaled corticosteroid activity with an allergen challenge model. J Allergy Clin Immunol (1997) 0.91
Standardization of inhalation provocation tests. Dose vs concentration of histamine. Chest (1982) 0.91
Beclomethasone dipropionate aerosol in perennial rhinitis. J Allergy Clin Immunol (1977) 0.90
Occupational asthma caused by cedar urea formaldehyde particle board. Chest (1982) 0.90
Self-injection with olive oil. A cause of lipoid pneumonia. Chest (1995) 0.90
Comparative assessment of safety and efficacy of inhaled corticosteroids: report of a committee of the Canadian Thoracic Society. Eur Respir J (1998) 0.89
Regular inhaled salbutamol : effect on airway responsiveness to methacholine and adenosine 5'-monophosphate and tolerance to bronchoprotection. Chest (2001) 0.89
Salbutamol-induced increased airway responsiveness to allergen and reduced protection versus methacholine: dose response. J Allergy Clin Immunol (1996) 0.89
Pulmonary emphysema associated with the FZ alpha 1-antitrypsin phenotype. Can Med Assoc J (1981) 0.89
Effect of Sch1000 in allergen-induced asthma. Clin Allergy (1978) 0.88
How best to measure airway responsiveness. Am J Respir Crit Care Med (2001) 0.87
Correlation of bronchial responsiveness to diluent and to histamine. Ann Allergy (1982) 0.87
Recent trends in the use of inhaled beta 2-adrenergic agonists and inhaled corticosteroids in Saskatchewan. CMAJ (1995) 0.87
Pulmonary function in Pi M and MZ grainworkers. Chest (1986) 0.87
Respiratory health risks in farmers. Ann Intern Med (1981) 0.86
Bronchiolitis obliterans and Mycoplasma pneumonia. Respir Med (1991) 0.85
Acquired persistent increase in nonspecific bronchial, reactivity associated with isocyanate exposure. Ann Allergy (1982) 0.85
Bronchial inhalation tests. I. Measurement of nonallergic bronchial responsiveness. Ann Allergy (1985) 0.85
Constrictive bronchiolitis and ulcerative colitis. Can Respir J (1999) 0.85
Increased airways responsiveness in swine farmers. Chest (1991) 0.85
The effect of helium on nasal resistance and nasal flows. Am Rev Respir Dis (1979) 0.84
Effect of pH on bronchial response to inhaled histamine. Thorax (1982) 0.84
Regular salbutamol use increases CXCL8 responses in asthma: relationship to the eosinophil response. Eur Respir J (2003) 0.84
The role of thromboxane in allergen-induced asthmatic responses. Eur Respir J (1991) 0.84
Measurement of responsiveness to inhaled histamine: comparison of FEV1 and SGaw. Ann Allergy (1983) 0.83
Improved accuracy and precision of single-breath CO diffusing capacity measurements. J Appl Physiol Respir Environ Exerc Physiol (1981) 0.83
Effect of breath-hold time on DLCO(SB) in patients with airway obstruction. J Appl Physiol (1985) (1985) 0.83
Airway responsiveness to inhaled histamine in chronic obstructive airways disease. Chronic bronchitis vs emphysema. Chest (1988) 0.83
Letter: Creatinine clearance and age. Lancet (1975) 0.83
Is there a negative correlation between malignancy and respiratory atopy? Ann Allergy (1979) 0.83
Nasal airway inspiratory resistance. Am Rev Respir Dis (1979) 0.83
Sporobolomyces: a possible cause of extrinsic allergic alveolitis. J Allergy Clin Immunol (1983) 0.82
Effect of indomethacin on allergen-induced asthmatic responses. J Appl Physiol (1985) (1989) 0.82
Occupational obstructive disorders: nonspecific airways obstruction and occupational asthma. Med Clin North Am (1990) 0.82
Ethnicity as a possible factor contributing to the development of chronic airflow limitation and asthma. Clin Invest Med (1990) 0.82
Eosinophilic bronchitis as a cause of cough. Chest (2000) 0.81
Comparison of 3 different doses of budesonide and placebo on the early asthmatic response to inhaled allergen. J Allergy Clin Immunol (1998) 0.81
Lobar pneumonia caused by Mycoplasma pneumoniae. Can Med Assoc J (1981) 0.81
Dynamic measurements of CO diffusing capacity using discrete samples of alveolar gas. J Appl Physiol Respir Environ Exerc Physiol (1983) 0.81
Localization of emphysema within the lung. An hypothesis based upon ventilation/perfusion relationships. Chest (1982) 0.80
High-frequency oscillatory ventilation of a canine bronchopleural fistula. Crit Care Med (1989) 0.80